
1. antimicrob agents chemother. 2011 oct;55(10):4858-65. doi: 10.1128/aac.01748-10. 
epub 2011 jun 27.

genomewide scan reveals amplification mdr1 common denominator of
resistance mefloquine, lumefantrine, artemisinin plasmodium chabaudi
malaria parasites.

borges s(1), cravo p, creasey a, fawcett r, modrzynska k, rodrigues l, martinelli
a, hunt p.

author information: 
(1)uei malária, centro de malária e outras doenças tropicais, instituto de
higiene e medicina tropical, universidade nova de lisboa, rua da junqueira no.
100, 1349-008 lisbon, portugal. sofiaborges@hotmail.com

multidrug-resistant plasmodium falciparum malaria parasites pose threat to
effective drug control, even artemisinin-based combination therapies (acts).
here used linkage group selection solexa whole-genome resequencing to
investigate genetic basis resistance component drugs acts. using the
rodent malaria parasite p. chabaudi, analyzed uncloned progeny a
genetic backcross mefloquine-, lumefantrine-, and
artemisinin-resistant mutant as-15mf genetically distinct sensitive clone, 
aj, following drug treatment. genomewide scans selection showed parasites
surviving drug treatment bore duplication segment chromosome 12
(translocated chromosome 04) present as-15mf. whole-genome resequencing
identified size duplicated segment position chromosome 4.
the duplicated fragment extends ∼393 kbp contains 100 genes,
including mdr1, encoding multidrug resistance p-glycoprotein homologue 1. 
therefore show resistance chemically distinct components acts is
mediated genetic mutation, highlighting possible limitation of
these therapies.

doi: 10.1128/aac.01748-10 
pmcid: pmc3186966
pmid: 21709099  [indexed medline]

